2002 – 3rd ESNI COURSE | Tampere (Finland) | 11-14 September
I Day
Regulatory immune-responses in the nervous system
- An overview on regulatory T cells (D. Wraith)
- The dual role of NKT cells in autoimmunity (L. Van Kaer)
- Evasion of clearance by CD(+ cells in autoimmunity (M. Brahic)
- The genetics of complex traits (D.A.S. Compston)
- The role of T cells in the nervous system. A general overview (H. Wekerle)
- Antigen specific CD8+ T cells in EAE/MS (R. Liblau)
- Regulation of immune response by residente cells of the central nervous system (J. Antel)
- The role of CD8+ cells in myositis (R. Gold)
II Day
Humoral factors in neurological disease
- Activation to cell death: humoral factors in the immunopathogenesis of neurological disease (D. Linington)
- Chemokines and microglia in the developing CNS (D. Male)
- Animal models for inherited neuropaties: an unexpected link to neuroimmunology (R. Martini)
- Connections between the brain and the immune system – How real are they? (R.O. Weller)
- The current state of peripheral neuropathies with anti-glucolipid antibodies (H. Willison)
- Paraneoplastic antibodies – what determines the target antigens? (J. Honnorat)
- Antibodies and cytokines in epilepsy (J. Peltola)
- Antibodies in peripheral and CNS disordes (A. Vincent)
III Day
Neuroinflammation
- General overview on mechanisms of immune mediated CNS damage (H. Perry)
- CNS tissue damage mediated by Class I restricted T-cells (H. Neumann)
- The role of microglia in immune mediated tissue damage (I. Alafuzoff)
- Cytokine mediated brain damage (L. Probert)
- Pathagenesis of paraneoplastic encephalitis (R. Voltz)
- Pathagenesis of HIV-dementia (M. Tardieu)
- Patterns and mechanisms of tissue damage in multiple sclerosis (H. Lassmann)
- Rationale for early intervention in multiple sclerosis (G. Comi)
IV Day
Neuroimmunopharmacology
- Intravenous immunoglobulin: how might in work (N. Scolding)
- Chemokine/chemokine receptors as drug targets in neuroinflammation (A. Ericsson – Dahlstrand)
- Matrix metalloproteases-new therapeutic target (A. Miller)
- Antiexcitotoxic treatment in neuroinflammation (T. Smith)
- The immunoregulatory effects and therapeutic use of corticosteroids in immuno mediated diseases (I. Elovaara)
- Strategies for strong immunosuppresion in CNS and PNS inflammatory diseased (R.Q. Hintzen)
- Emerging gene- and stem-cell therapy approaches for demyelonating disorders (G. Martino)